LLY•benzinga•April 8, 2025 at 03:07 PM

Trump Administration Reverses Biden's Plan For Medicare Coverage Of Obesity Drugs Like Ozempic And Zepbound

CMS finalizes 2026 Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries.

Read the full article from the original source for complete details and context.

Article published on April 8, 2025 by benzinga